In a world where breast cancer continues to affect millions of lives, it is crucial that companies like Olight step up and stand together in the fight against this formidable adversary. We proudly present our annual breast cancer charity sale campaign, a shining example of our unwavering commitment to supporting this vital cause.
💓The Essence of Our Campaign
Our breast cancer charity sale campaign is more than just a fundraising event; it is a global beacon of hope, symbolizing unity, and a testament to our dedication to creating a world without breast cancer. It signifies our belief that every contribution, no matter how small, brings us one step closer to a cure. In a world where breast cancer continues to affect countless lives, we understand the importance of supporting breast cancer initiatives.
We are proud to highlight that our campaign has been consistently conducted in 13 countries (US, AU, CA, UK, DE alongside several other countries) over the past three years, emphasizing its worldwide impact and reach.
💓Statistics Speak Volumes
Summarizing over four years of events, Olight has made significant contributions to breast cancer causes on a global scale, with a total of $596,243.43 raised during this period. Their unwavering dedication to this noble cause is evident in the funds they have raised:
👉In 2020,
Olight launched its breast cancer charity sale campaign, where the proceeds, totaling $192,902, were dedicated to supporting breast cancer programs.
👉In 2021
Our campaign continued to shine brightly, raising $167,205 for the fight against breast cancer. We also offered a special "HOPE KIT" featuring an i3T EOS Flashlight, adding a unique touch to our support for this noble cause.
👉In 2022
Olight's dedication remained unwavering, contributing $158,523 to support breast cancer initiatives worldwide.
These numbers transcend mere figures; they signify the profound impact of our work. Over 10,000 patients have experienced the life-altering effects of these funds, providing essential aid in their unwavering battle against breast cancer. Through our expansive global partner network, spanning continents and cultures, we've dedicated ourselves to fostering positive change in the fight against this devastating disease.
💓Online Illumination: Spreading Hope Through Global Partnership
This year, we are thrilled to announce our expansive online charity sale campaign for the 4th consecutive year, which again takes place in 13 countries. Our charity sale product, the "imini 2 pink", will lead the charge, alongside several other products.
The funds raised from this year's charity sale, totaling $77,313.43, will be dedicated to supporting various local and international causes, aiming to make a positive impact on communities in need.
In Australia, all proceeds from the sales of the imini 2 pink will be donated to the National Breast Cancer Foundation in Australia. For customers in other countries, product availability and donation conditions may vary.
The charity sale event items will be available for purchase on olightstore.com.au from 8:00 PM on October 25 to 11:59 PM on October 27 AEDT for customers in Australia.
For customers in other countries, availability and donation details will depend on the specific conditions of each country. Stay tuned to their respective country's websites for updates on the charity sale event. We look forward to your participation in this meaningful cause and joining us in making a significant difference in the fight against breast cancer.
💓Shining a Spotlight on Our Offline Activities
A notable addition this year was an offline setting in the USA: Olight established an Awareness Booth in Frisco, Dallas, in partnership with NBCF. This booth provided breast cancer information and fostered community participation against the disease. Olight also gifted volunteers and patients with special flashlights, pink pouches, etc. on site.
In addition to our online efforts, this year, our commitment to the cause was acknowledged as Olight was honored with the NBCF 3rd Anniversary Partner Award at the NBCF office in Dallas. This recognition reaffirms our dedication to making a real impact in the fight against breast cancer. Mavis Xiao, Vice President of Olight, said, "It's an honor to stand by NBCF in this mission for three years. As a global corporate citizen, Olight aims not only to illuminate the world with lighting but also to infuse it with HOPE." Meanwhile, Brooke Adams, Sr. Director of Charitable Giving and Strategic Partnerships at NBCF, commented "NBCF thanks Olight for its dedication to supporting breast cancer awareness and our mission of Helping Women Now. We look forward to more collaborations with Olight where we will continue to illuminate patients’ lives."
Furthermore, we are delighted to reintroduce the “HOPE KIT” in 2023, featuring the donation of imini 2 pink 200pcs, i3T EOS Pink Camouflage 100pcs, and Obags 80pcs to the NBCF for breast cancer patients. This initiative underscores our ongoing commitment to supporting awareness while directly contributing to the well-being of those in the midst of this battle.
💓Elevating Our Values
At Olight, we believe that our brand should stand for something more significant than just profit. Our brand vision is closely aligned with the concept of spreading hope and light around the world, while our core values are rooted in compassion and solidarity. Our mission is to inspire society to embrace our customer-centric approach and our vision of "Illuminating Your World" with flashlights and optimism.
As we mark the progress of our ongoing breast cancer charity sale campaign we extend an open invitation to everyone to become part of this noble cause. Together, we can make a difference. Together, we can turn the tide against breast cancer.
In conclusion, our breast cancer charity sales campaign is a testament to Olight's commitment to creating a world where breast cancer is no longer a threat. It's not just about raising funds; it's about raising awareness, fostering unity, and igniting hope. Join us in this journey, and together, we can empower hope, defeat breast cancer, and save lives.
